inclisiran sodium injection

DRUG2 trials

Sponsors

Novartis Pharmaceuticals, Shanghai Minwei Biotechnology Co., Ltd

Conditions

Coronary Heart DiseaseMixed Dyslipidemia

Phase 2

Phase 2 Clinical Study of MWX203 Injection Alone or in Combination With Inclisiran Sodium Injection in Patients With Mixed Dyslipidemia

RecruitingNCT07803822

Shanghai Minwei Biotechnology Co., LtdMixed Dyslipidemia

Start: 2026-09-25End: 2028-02-01Target: 216Updated: 2026-09-08

Phase 4

Inclisiran Effectiveness in China: a Pragmatic Randomized Trial

Active, not recruitingNCT06941792

Novartis PharmaceuticalsCoronary Heart Disease

Start: 2025-06-17End: 2027-04-30Updated: 2026-05-29